Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Pr Paclitaxel for injection 300mg/50mL (6mg/mL) vials (Biolyse Pharma, Canada)
Section 19A approved medicine
Pr Paclitaxel for injection 300mg/50mL (6mg/mL) vials (Biolyse Pharma, Canada)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Current
Medicines in short supply/unavailable
PACLITAXEL ACCORD paclitaxel 300 mg/50 mL concentrated injection vial - ARTG 219556
Indication(s)
- Paclitaxel is indicated for the treatment of metastatic carcinoma of the breast after failure of standard therapy.
- Paclitaxel is indicated for the treatment of non-small cell lung cancer (NSCLC).
Images
